Panelists discuss how bacterial infections, environmental triggers, and microbiome imbalances cause bronchiectasis exacerbations, leading to increased cough, phlegm, fatigue, and hemoptysis.
Clinical Brief: Causes and Management of Bronchiectasis Exacerbations
Main Discussion Topics
Key Points for Physicians
Notable Insights
Comprehensive management must address multiple dimensions, including infection control, inflammation reduction, mucus clearance enhancement, and hydration.
Clinical Significance
Effective bronchiectasis exacerbation management requires targeted multimodal therapies addressing both immediate symptoms and underlying mechanisms to prevent recurrence.
Addressing KRAS Resistance, RAS(ON) Therapies Find Limelight at AACR
May 5th 2025KRAS-targeted therapies, including daraxonrasib and zoldonrasib, show promise in overcoming resistance in cancer treatment, as highlighted at the 2025 meeting of the American Association for Cancer Research (AACR).
Read More